Disal

Quick links to important sections

Disal

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Disal

Property Description
Active ingredient Salsalate (Salicylsalicylic acid)
Form Solid oral preparation (Tablet, Capsule)
Pharmacological class Nonsteroidal Anti-inflammatory Drug (NSAID)
General purpose Relief of pain and management of inflammation
Origin Synthetic (Non-acetylated salicylate)

Identity and Pharmacological Classification

Disal is a prescription medicine containing the active ingredient Salsalate, which is classified as a Nonsteroidal Anti-inflammatory Drug (NSAID). Disal is supplied as a solid oral preparation, such as an oral tablet or capsule, intended for systemic administration via the oral route. The drug entity belongs to the broader family of salicylates, agents that are clinically recognized for their capacity to mitigate both pain and inflammation. This designation establishes Disal's core utility in addressing conditions that involve chronic or acute discomfort and swelling.


Composition and Differentiation of Salsalate

The medicinal activity of Disal is centered on its sole active ingredient, Salsalate, chemically known as salicylsalicylic acid. Salsalate is structurally defined as a non-acetylated salicylate, a key factor distinguishing it from acetylsalicylic acid (Aspirin). This compound functions as a pro-drug; it is reliably hydrolyzed in the body into the active component, salicylic acid, which then exerts the anti-inflammatory effect. Salsalate provides anti-inflammatory activity while being associated with less gastrointestinal distress than Aspirin, which can be an important differentiating factor for patients requiring long-term management.


General Purpose of Disal

The general purpose of Disal is to provide relief by functioning as a dual-action agent: a non-narcotic analgesic and an anti-inflammatory compound. Its core utility is to intervene in the body's natural processes that lead to the experience of pain and the manifestation of swelling, stiffness, and heat associated with inflammation. As a typical use scenario, the medicine is employed to help relieve chronic discomfort and inflammation. Its classification as a non-narcotic agent ensures that its pain-relieving effects are achieved without the central nervous system depression associated with opioid medications.

Regulatory References

  1. MedlinePlus, Salsalate
  2. National Library of Medicine, Salsalate

What side effects are possible with Disal?

Possible Side Effects and Safety Information

The safety profile of Disal (Salsalate), consistent with its classification as a Nonsteroidal Anti-inflammatory Drug (NSAID), is defined by officially documented risks spanning several body systems. Regulatory documents emphasize the potential for serious adverse events associated with the NSAID class, alongside common reactions linked to its salicylate component.

Serious Systemic Risks and Safety Patterns

The most significant documented safety concerns involve the potential for serious Cardiovascular (CV) thrombotic events, such as myocardial infarction (heart attack) and stroke, and serious Gastrointestinal (GI) events, including bleeding, ulceration, and perforation of the stomach or intestines. Regulatory data indicate that the risk of these serious CV and GI events may increase with duration of use and higher doses, and that GI events can occur at any time without warning symptoms [NIH DailyMed].

Other serious reactions documented in regulatory sources include severe skin reactions (e.g., Stevens-Johnson Syndrome (SJS)), severe hepatic (liver) injury, and anaphylactic-like reactions.

Common Adverse Reactions and System-Organ Classes

The most frequent adverse reactions listed in regulatory documents involve the Gastrointestinal System (e.g., nausea, upset stomach) and the Oto-acoustic/Nervous System. Common salicylate-related effects include tinnitus (ringing in the ears) and temporary hearing impairment [MedlinePlus]. Potential effects are also documented in the Renal, Hepatic, and Dermatologic systems.

Population-Specific Constraints

Disal is contraindicated for treating pain following Coronary Artery Bypass Graft (CABG) surgery. Use is also subject to specific constraints for sensitive populations: it must be avoided from 30 weeks gestation onward in pregnancy, and is not recommended for children with viral illnesses due to the risk of Reye’s Syndrome [FDA].

Overdose and Emergency Response

Overdose Scope

Element Regulatory Statement
Documented overdose presentations Initial signs of toxicity include tinnitus, vomiting, and hyperventilation. More severe intoxication involves fever, confusion, seizures, and a transition from respiratory alkalosis to a potentially life-threatening high anion gap metabolic acidosis.
Physiological systems affected Central Nervous System (CNS), metabolic systems, respiratory system (pulmonary edema), and renal system (acute renal failure).
Exposure-related factors Toxicity can result from a single large ingestion or from chronic cumulative exposure, which is often misdiagnosed and noted as a risk factor, particularly in older adults.
When immediate medical help is required Seek immediate medical attention or contact emergency services immediately upon suspicion of overdose or observation of any symptoms of toxicity (e.g., persistent vomiting, severe confusion).

Overdose Classifications (High-level)

Element Regulatory Statement
Severity classification Classified as a medical emergency with risk of severe, life-threatening outcomes, including cerebral edema and cardiovascular collapse.
Overdose-context constraints Management is entirely supportive, as no specific antidote is known. Treatment involves procedures such as urine alkalinization and activated charcoal, with hemodialysis reserved for severe cases or intractable acidosis.

Resulting Overdose Structure

Official overdose statements:

  • Symptoms like tinnitus and hyperventilation define the initial clinical presentation documented in regulatory sources.
  • Immediate medical help is required due to the risk of severe complications, including metabolic acidosis and acute renal failure.
  • The established treatment protocol emphasizes supportive care and procedures like urine alkalinization, as no specific antidotal agent is available.

Connection to the overall overdose profile (2–4 sentences): The official regulatory documents define the overdose profile of Salsalate through the distinct symptoms of salicylate toxicity and the mandatory requirement to seek immediate medical attention due to the risk of rapid clinical deterioration. This profile establishes that care is focused on continuous monitoring and supportive procedural interventions to mitigate documented, life-threatening organ system complications.

Therapeutic Uses of Disal

What Disal Treats: Main Uses and Benefits

Disal (Salsalate) may be part of symptomatic management for inflammatory musculoskeletal conditions, and provides support that helps address the overall symptom load of chronic disease manifestations. It is commonly used across conditions characterized by periods of heightened symptoms and systemic inflammation, such as Rheumatoid Arthritis, Osteoarthritis, and Ankylosing Spondylitis. It is also relevant for the supportive management of Juvenile Idiopathic Arthritis (JIA) in appropriate patient groups.

The medication is relevant for managing symptoms that interfere with daily comfort, specifically the mild to moderate pain and tenderness associated with joint inflammation. It is also used when groups of symptoms, such as morning stiffness and swelling, appear suddenly or fluctuate. By addressing these inflammatory and irritative states, Disal contributes to easing the overall symptom load during periods of heightened symptoms.

Disal is commonly used to help with the stiffness and swelling that may lead to symptoms that interfere with daily functioning. When stiffness and swelling are managed, this may assist with maintaining functional stability, which is relevant when symptoms become more disruptive during flare-ups. This support assists with maintaining functional stability when symptoms interfere with routine activities.

“This support may assist with maintaining functional stability, which is relevant when symptoms become more disruptive during flare-ups.”

Quick Fact: Supportive Management of Chronic Joint Pain and Inflammation

Regulatory References

  1. SALSALATE tablet - DailyMed - NIH

Eligibility and Restrictions for Use

Who Can and Cannot Use Disal?

The eligibility for using Disal (Salsalate) is formally defined by regulatory documents based on specific population restrictions and contraindications.

Contraindications

Use is absolutely contraindicated for patients with a known hypersensitivity to Salsalate, aspirin, or any other Nonsteroidal Anti-inflammatory Drug (NSAID) that resulted in allergic-type reactions (e.g., asthma, urticaria). Disal is also prohibited for treating pain in the setting of Coronary Artery Bypass Graft (CABG) surgery.

Age and Condition Restrictions

The safety and effectiveness of Disal have not been established in children. Use is not recommended for children and teenagers with viral illnesses, such as flu or chickenpox, due to the risk of Reye's Syndrome. Caution should be exercised when treating older adults (65 years and older), who are at greater risk for serious gastrointestinal events.

Conditional Use

Great care is required, often with monitoring, for patients with chronic renal insufficiency or liver dysfunction. Pregnant women are categorized as avoid use starting at 30 weeks gestation and use is limited to the lowest effective dose for the shortest duration between 20 and 30 weeks. Use during lactation also requires caution.

What should I know about interactions with other medicines?

Disal (Salsalate) interactions are officially documented across several categories, primarily impacting drug exposure and physiological effect. Co-administration with Aspirin or other salicylates is not generally recommended due to the additive risk of increasing the active metabolite's plasma concentration to potentially toxic levels. The use of high-dose salicylates, and thus Disal, is formally contraindicated with the drug Dichlorphenamide.

The medicine affects drug clearance and plasma protein binding. Co-administration with Lithium results in an elevation of plasma lithium levels, and it may enhance the toxicity of Methotrexate by competitively inhibiting its accumulation. Furthermore, substances that lower urine pH (acidifying agents) may increase Salsalate's concentration by decreasing its urinary excretion.

Pharmacodynamic interactions are also officially documented. Disal may enhance the anticoagulant effect of agents like Warfarin, synergistically increasing the risk of serious gastrointestinal bleeding. Conversely, it may diminish the antihypertensive effect of ACE-inhibitors and ARBs, and reduce the natriuretic effect of diuretics. Alcohol consumption also officially increases the risk of serious gastrointestinal adverse events. Specific population notes advise careful monitoring for patients with chronic renal insufficiency or those receiving anticoagulants.

Mechanism of Action

The mechanism of Disal is executed by its active metabolite, salicylic acid, which acts through two primary systems to influence the activity of inflammatory and thermoregulatory pathways.

Dual Modulation of Inflammatory Mediators and Gene Control

Disal's action involves complementary mechanisms by which it influences both immediate and transcriptional inflammatory processes. It acts as a reversible inhibitor of the Cyclooxygenase (COX) enzymes to limit the synthesis of prostaglandins, which are lipid mediators that increase nociceptor sensitivity, and it directly suppresses key genetic regulators like NF-κB by inhibiting IKK-β. This dual engagement influences both the immediate generation of lipid mediators and the transcriptional activity of pro-inflammatory proteins.

Central Regulation of Body Temperature

The active metabolite influences the hypothalamus—the brain's thermoregulation center—by reducing the level of prostaglandin E₂ (a mediator involved in setting the body's temperature) in this area. This engagement facilitates a downward adjustment of the body's elevated temperature set-point, which initiates physiological mechanisms for heat dissipation.

Mechanistic Specificity on Platelet Activity

As a non-acetylated salicylate, Disal's active component only causes reversible and weak COX inhibition and does not irreversibly modify platelet COX-1. This specific molecular limitation results in a negligible influence on Thromboxane A₂ (TXA₂) synthesis and subsequent platelet aggregation.

Dosage and Administration Information

Disal is an oral medication administered for systemic use, typically provided in tablet form at strengths such as 500 mg and 750 mg. The standard usage pattern involves taking the medicine in divided doses, two or three times daily, which is necessary to maintain consistent therapeutic levels of the active component in the body.

Official Administration Guidelines

Feature Official Labeled Instruction
Standard Adult Dose The usual adult maintenance regimen is a total of 3000 mg (3 grams) per day, adjusted to suit individual requirements. The dosage must adhere to the principle of using the lowest effective dose for the shortest duration necessary.
Timing with Meals Disal may be taken with or without food.
Onset of Full Effect Full clinical benefit may not be evident for 3 to 4 days of continuous use, which is when steady-state plasma salicylate levels are achieved.
Use Restriction Patients should not take any other salicylate products (e.g., aspirin) concurrently to help prevent potentially elevated and toxic concentrations of the active drug component.

Population-Specific Use

Official prescribing information establishes specific usage rules for certain populations. For older adults (geriatric patients), a lower dosage may be required to achieve therapeutic concentrations and help minimize potential adverse events. Dosage recommendations and indications for use in pediatric patients (children) have not been established in the official prescribing information. The overall approach to using Disal is defined by this structured schedule and these population constraints, ensuring the medicine is administered strictly according to regulatory standards.

Recent Clinical Evidence

Research Evidence / Overview of Studies

Research into Compound X

Initial research focused on how the compound might affect systems related to inflammation. Early in vitro and animal studies investigated whether the compound engaged specific cellular targets.

Clinical Trials: Symptom Management

A limited number of randomized controlled trials (RCTs) and observational studies have investigated Compound X. These studies primarily focused on adult populations experiencing chronic musculoskeletal discomfort.

  • Studies evaluated changes in joint function and reported severity of symptoms following compound administration.
  • Trials typically lasted between 4 and 12 weeks. Findings were mixed, with some studies reporting a statistically significant difference in reported symptom changes compared to placebo, while others did not report a statistically significant difference.
  • Studies investigated whether a persistent change in inflammatory markers could be observed over the study period. Results varied depending on the specific inflammatory marker being monitored.

Combination Therapy (Compound X and Compound Y)

Evaluations focused on the compound's potential role in symptom management when administered in combination with Compound Y.

  • Studies examined the time course of reported symptom changes following administration of the combination, comparing this against the administration of Compound X alone.
  • Some clinical data focused on whether the combination might influence patient-reported quality of life metrics compared to single-compound use.
  • Research has not evaluated the safety of co-administering this compound with common classes of drugs used for pain relief, such as NSAIDs, and this combination may require further study.

Safety and Tolerability

Reported adverse events in clinical trials included gastrointestinal discomfort and headache, and were commonly described as mild and temporary (or 'transient') by researchers.

  • Research focused only on adult populations; pediatric studies have not been reviewed.
  • No studies reviewed explicitly examined the safety profile in patients with pre-existing kidney or liver conditions.

Frequently Asked Questions (FAQ)

Common questions about Disal (FAQ)

Q: What is Disal used for?

Disal is a prescription medication primarily used to manage hypertension (high blood pressure). It may also be used to treat certain conditions involving fluid retention, such as edema (swelling) associated with congestive heart failure.

Q: How does Disal work?

Disal belongs to a class of drugs known as diuretics, often called "water pills." It works by increasing the amount of salt and water the kidneys remove from the blood. This process reduces the volume of fluid in the blood vessels, which helps to lower blood pressure and relieve swelling.

Q: Can I stop taking Disal once my blood pressure improves?

No, you should not stop taking Disal without first speaking to your healthcare provider. Even if your blood pressure measurements appear normal, the medication is still working to manage your condition. Stopping abruptly could cause your blood pressure to rise significantly, which may increase the risk of serious health issues like stroke or heart attack. Your doctor will determine if and how the dose should be adjusted or discontinued.

Q: What are the common side effects of Disal?

Common side effects of Disal can include:

  • Increased urination, especially when you first start taking the medication.
  • Dizziness or lightheadedness, particularly when standing up quickly (orthostatic hypotension).
  • Electrolyte imbalances, such as low potassium or magnesium levels.
  • Headache.
  • Fatigue or weakness.

If side effects are bothersome or persistent, consult your healthcare provider.

Q: Does Disal interact with other medications?

Yes, Disal can interact with several other medications, which may alter their effects or increase the risk of side effects. Key interactions include:

  • Lithium: Disal can increase the level of lithium in the blood, potentially leading to toxicity.
  • Digoxin: The risk of digoxin toxicity may increase due to electrolyte changes caused by Disal.
  • Nonsteroidal anti-inflammatory drugs (NSAIDs), such as ibuprofen: These can reduce the blood pressure-lowering effect of Disal.

It is essential to inform your healthcare provider about all prescription, over-the-counter, and herbal supplements you are taking to check for potential interactions.

Q: Should I take Disal with food?

Disal is usually taken once daily and can be taken with or without food.

However, taking it with a meal or snack may help reduce stomach upset if you experience it. Consistency is key, so try to take it at the same time each day to maintain a steady level in your body. Because it increases urination, many people prefer to take it in the morning to avoid waking up during the night.

How should Disal be stored and disposed of?

Disal (Salsalate) must be stored at Controlled Room Temperature, defined as 20 C to 25 C (68 F to 77 F), with permitted excursions up to 30 C (86 F). The medication must be kept away from excess heat and moisture; therefore, storage in a bathroom is prohibited. To maintain product integrity, keep the tablets in the container they came in, with the lid tightly closed. The medicine must be stored out of the sight and reach of children in a secure location, such as one that is up and away. For disposal, follow any specific instructions on the labeling. Disal is not recommended to be flushed. If a take-back program is unavailable, mix the unused medicine with an undesirable substance like coffee grounds, place it in a sealed bag, and discard it in the household trash. Always scratch out all personal information on the label.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Disal found in:

A-Z Index: